Vomiting News and Research

RSS

Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.

Acupuncture more effective at reducing nausea and vomiting after major breast surgery than the leading medication

The researchers also found that patients who underwent the 5,000-year-old Chinese practice reported decreased postoperative pain and increased satisfaction with their postoperative recovery. In conducting the trial, the researchers also demonstrated that the pressure point they stimulated possesses previously unknown pain-killing properties.

22 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Intravenous access for ear tube placement surgery has no added benefit

Children who had intravenous (IV) access for ear tube placement surgery spent more time in the operating room and in the hospital and required more pain medication than children who underwent the same procedure without IV access

21 Sep 2004

Increase in cases of pertussis (whooping cough) in Indiana

Pertussis is a contagious illness caused by bacteria. It occurs in infants and young children more often than older children and adults. Adults with milder, undiagnosed symptoms can transmit the disease to infants and children.

20 Sep 2004

Study compares coblation tonsillectomy to traditional method of removing tonsils

Tonsillectomy remains one of the most common childhood surgeries with an increasing number of the surgeries being done to treat obstructive sleep apnea or sleep disordered breathing.

17 Sep 2004

Wyeth gets approval for needle-less syringe for the treatment of hemophilia

Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.

14 Sep 2004

Painful and damaging chemotherapy may one day be a thing of the past

Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them.

10 Sep 2004

50 year old frozen smallpox vaccines are nearly 100 percent effective

Diluted doses of a smallpox vaccine, originally manufactured in the 1950s and stored as a frozen preparation, are nearly 100 percent effective, allowing for expansion of the current stockpile if needed, according to an article in the September 8 issue of JAMA.

8 Sep 2004

Health Canada is advising consumers of a recall of potassium replacement products

Health Canada is advising consumers of a recall of potassium replacement products distributed in Canada by EuroPharm International Canada Inc. and Laboratoire Riva Inc. Potassium replacement products are used in the treatment and prevention of potassium depletion.

2 Sep 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

High-resolution images reveal the molecular rearrangements that rotavirus uses to break into cells

High-resolution images constructed by researchers at Children's Hospital Boston and Harvard Medical School reveal the molecular rearrangements that rotavirus – the most common cause of severe, dehydrating diarrhea and vomiting in children worldwide – uses to break into cells.

25 Aug 2004

Researchers find way to detect dangerous brain swelling in diabetic children

A rare swelling of the brain that is nonetheless the most common diabetes-related cause of death for children with the disease could be caught earlier — potentially saving lives — if practitioners learn to recognize key signs, researchers at the University of Florida report.

18 Aug 2004

Scopolamine prevents and relieves motion sickness - but possibly with more adverse effects than alternatives

Researchers from the Cochrane Collaboration have analysed all trials of scopolamine for motion sickness. They found 12 trials, mostly done in healthy young men in the navy.

12 Aug 2004

First human cases of West Nile virus in Mississippi

The seven human cases occurred in: Covington (1), Harrison (1), Lincoln (1), Leflore (1), Rankin (2) and Simpson (1) counties; these numbers include the five suspected cases reported last week by the Mississippi State Department of Health.

11 Aug 2004

Painless heart attacks often result in greater fatality rates than painful episodes

Painless heart attacks or heart conditions can be commonly overlooked and undertreated at the hospital, often resulting in greater fatality rates than painful episodes.

9 Aug 2004

Knowledge about oral and head and neck cancer is severely lacking in the American public

Most adult Americans know how to light a cigarette and order a drink, but a great number of them are clueless about the consequence of these two destructive habits – oral and head and neck cancer.

9 Aug 2004

Smart drug that targets cancer cells in the brain following removal of a tumor

The use of a "smart" drug that targets cancer cells in the brain following removal of a tumor may provide treatment that can extend the survival of people with the most common form of primary malignant brain tumor, glioblastoma multiforme (GBM).

3 Aug 2004

College freshmen, beware of dorm diseases

High school graduates have more in common with newborn babies than one would think. Although departing the proverbial family nest, incoming college freshmen need vaccinations, too.

2 Aug 2004

Rapid detection of anthrax inhalation

Authors of a research letter in this week’s issue of THE LANCET outline progress in the ability to rapidly detect anthrax inhalation in the event of bioterrorist attacks.

29 Jul 2004

Study shows frovatriptan effective in preventing menstrual associated migraine

A study conducted by researchers at Thomas Jefferson University, Philadelphia, and published Tuesday, July 27, 2004, in the journal Neurology, shows that Frova (frovatriptan), a triptan class migraine therapy with a long half life, significantly reduced the incidence of menstrual associated migraines (MAM) in women who took the medication preventively, in advance of anticipated onset of headache.

29 Jul 2004